{
  "release_id": "5dcd9b263fe17744",
  "id": "cardio:guideline-uspstf-2022-aspirin",
  "owner": "cardio",
  "kind": "guideline",
  "slug": "guideline-uspstf-2022-aspirin",
  "name": "USPSTF 2022: aspirin use to prevent CVD",
  "aliases": [
    "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "The 2022 recommendation statement issued by the US Preventive Services Task Force on taking low-dose aspirin to prevent cardiovascular disease in adults who do not already have it. Its advice differs by age: an individual decision for adults aged 40 to 59 at higher risk, and advice against starting at 60 or older. This statement updates its 2016 recommendation.",
  "summary_technical": "JAMA 2022;327(16):1577-1584, doi 10.1001/jama.2022.4983, PMID 35471505. The USPSTF page dates the final statement April 26, 2022. Only the PubMed abstract and that date line were read. Grades as the abstract labels them: C for adults aged 40 to 59 whose 10-year risk is 10% or more (an individual decision) and D for adults 60 or older (against starting). The abstract says the Task Force also commissioned a modelling study of net benefit by age, sex and risk level; its results were not read. The USPSTF permits reuse of its work only under its copyright notice, so this atlas states the recommendations in its own words, with a citation and a link.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-10-15",
  "last_evidence_check": "2026-10-15",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "doi",
      "value": "10.1001/jama.2022.4983",
      "normalized_value": "10.1001/jama.2022.4983",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": true
    },
    {
      "scheme": "pmid",
      "value": "35471505",
      "normalized_value": "35471505",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": true
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart",
        "blood-vessels"
      ],
      "condition-area": [
        "risk-and-prevention"
      ]
    }
  },
  "payload": {
    "source": "cardio:uspstf-2022-aspirin",
    "issuers": [
      "core:uspstf"
    ],
    "edition": "2022 recommendation statement",
    "published": "2022-04-26",
    "planned_update": null,
    "status": "not_checked",
    "scope": "Primary prevention of cardiovascular disease with low-dose aspirin in adults aged 40 or older without known cardiovascular disease and not at increased bleeding risk.",
    "plain_interpretation": null
  },
  "content_digest": "186b8132ad56d452d30e936100cee65bd63ca6d52b5ac772b171ecfb36228681",
  "review": {
    "content_digest": "186b8132ad56d452d30e936100cee65bd63ca6d52b5ac772b171ecfb36228681",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "authored_by",
        "label": "Issuer: the Task Force is named as the author in the PubMed record",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "core:uspstf",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:pubmed-35471505-2026-10-15",
          "locator": "AuthorList, CollectiveName"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "guidelines/guideline-uspstf-2022-aspirin/",
  "context_path": "api/v1/context/cardio--guideline-uspstf-2022-aspirin.md"
}